Beverly Hills Private Wealth’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,526
Closed -$392K 323
2026
Q1
$392K Sell
4,526
-27
-0.6% -$2.59K 0.07% 224
2025
Q4
$437K Sell
4,553
-61
-1% -$5.92K 0.07% 197
2025
Q3
$439K Sell
4,614
-169
-4% -$15.5K 0.08% 203
2025
Q2
$417K Sell
4,783
-613
-11% -$52K 0.08% 207
2025
Q1
$485K Buy
5,396
+72
+1% +$6.44K 0.1% 179
2024
Q4
$425K Sell
5,324
-225
-4% -$19.5K 0.09% 193
2024
Q3
$500K Sell
5,549
-1,093
-16% -$91.9K 0.1% 186
2024
Q2
$523K Sell
6,642
-1,083
-14% -$88.8K 0.11% 179
2024
Q1
$673K Buy
7,725
+884
+13% +$75.4K 0.16% 146
2023
Q4
$564K Sell
6,841
-3,029
-31% -$231K 0.15% 149
2023
Q3
$773K Sell
9,870
-9,466
-49% -$792K 0.23% 100
2023
Q2
$1.63M Buy
19,336
+8,969
+87% +$772K 0.27% 87
2023
Q1
$836K Buy
10,367
+1,563
+18% +$127K 0.26% 95
2022
Q4
$684K Buy
+8,804
New +$714K 0.3% 84

Other funds holding MDT

Beverly Hills Private Wealth's MDT Position: Q2 2026 in Review

Beverly Hills Private Wealth sold out of Medtronic (MDT) in Q2 2026, closing a stake of 4,526 shares — an estimated $392K sold.

Beverly Hills Private Wealth first reported a position in MDT in Q4 2022 and held it in 14 quarters. The position peaked at $1.63M in Q2 2023. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Beverly Hills Private Wealth reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Beverly Hills Private Wealth sold 4,526 Medtronic shares in Q2 2026, an estimated $392K.
  • Beverly Hills Private Wealth first reported a position in Medtronic in Q4 2022 and held it in 14 quarters.
  • Beverly Hills Private Wealth's Medtronic position peaked at $1.63M in Q2 2023.
  • 2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Beverly Hills Private Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.